Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
Open Access
Abstract
Microtubule-associated doublecortin-like kinase 1 (DCLK1) is an accepted marker of tuft cells (TCs) and several kinds of cancer stem cells (CSCs), and emerging evidence suggests that DCLK1-positive TCs participate in the initiation and formation of inflammation-associated cancer. DCLK1-expressing CSCs regulate multiple biological processes in cancer, promote resistance to therapy, and are associated with metastasis. In solid tumor cancers, tumor epithelia, immune cells, cancer-associated fibroblasts, endothelial cells and blood vessels, extracellular matrix, and hypoxia all support a CSC phenotype characterized by drug resistance, recurrence, and metastasis. Recently, studies have shown that DCLK1-positive CSCs are associated with epithelial-mesenchymal transition, angiogenesis, and immune checkpoint. Emerging data concerning targeting DCLK1 with small molecular inhibitors, monoclonal antibodies, and chimeric antigen receptor T-cells shows promising effects on inhibiting tumor growth and regulating the tumor immune microenvironment. Overall, DCLK1 is reaching maturity as an anti-cancer target and therapies directed against it may have potential against CSCs directly, in remodeling the tumor microenvironment, and as immunotherapies.Keywords
Funding Information
- National Institutes of Health (R50CA233186, R01CA214017, R01DK119495)
This publication has 106 references indexed in Scilit:
- DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic CancerPLOS ONE, 2013
- Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanismJournal of Nanobiotechnology, 2011
- Identification of the putative intestinal stem cell marker doublecortin and CaM kinase‐like‐1 in Barrett's esophagus and esophageal adenocarcinomaJournal of Gastroenterology and Hepatology, 2011
- Metabolic Alterations in Highly Tumorigenic Glioblastoma CellsJournal of Biological Chemistry, 2011
- DCAMKL-1 Regulates Epithelial–Mesenchymal Transition in Human Pancreatic Cells through a miR-200a–Dependent MechanismCancer Research, 2011
- K-ras Mutation Targeted to Gastric Tissue Progenitor Cells Results in Chronic Inflammation, an Altered Microenvironment, and Progression to Intraepithelial NeoplasiaCancer Research, 2010
- CD13 is a therapeutic target in human liver cancer stem cellsJournal of Clinical Investigation, 2010
- Identification of a novel putative pancreatic stem/progenitor cell marker DCAMKL-1 in normal mouse pancreasAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2010
- Altered expression of a putative progenitor cell marker DCAMKL1 in the rat gastric mucosa in regeneration, metaplasia and dysplasiaBMC Gastroenterology, 2010
- Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancerJournal of Cellular and Molecular Medicine, 2010